121 related articles for article (PubMed ID: 2118879)
1. Treatment of cancer patients with recombinant interferon-gamma induces release of endogenous tumor necrosis factor-alpha.
Aulitzky WE; Aulitzky WK; Frick J; Herold M; Gastl G; Tilg H; Berger M; Huber C
Immunobiology; 1990 Jun; 180(4-5):385-94. PubMed ID: 2118879
[TBL] [Abstract][Full Text] [Related]
2. The in vivo immunomodulatory effects of recombinant interferon gamma plus recombinant tumor necrosis factor-alfa.
Urba WJ; Kopp WC; Clark JW; Smith JW; Steis RG; Huber C; Coggin D; Longo DL
J Clin Oncol; 1991 Oct; 9(10):1831-9. PubMed ID: 1919633
[TBL] [Abstract][Full Text] [Related]
3. Prolonged interferon-gamma application by subcutaneous infusion in cancer patients: differential response of serum CD14, neopterin, and monocyte HLA class I and II antigens.
Landmann R; Ludwig C; Wesp M; Fisscher A; Obrist R; Knüsli C; Denz H; Obrecht JP
J Interferon Res; 1992 Apr; 12(2):103-11. PubMed ID: 1374454
[TBL] [Abstract][Full Text] [Related]
4. Serum neopterin as a parameter for monitoring the course of renal cell carcinoma during interferon-gamma therapy.
Höbarth K; Szabo N; Hallas A; Aulitzky W; Marberger M
Clin Immunol Immunopathol; 1994 Mar; 70(3):241-4. PubMed ID: 8313661
[TBL] [Abstract][Full Text] [Related]
5. Enhanced serum levels of beta-2-microglobulin, neopterin, and interferon-gamma in patients treated with recombinant tumor necrosis factor-alpha.
Aulitzky WE; Tilg H; Herold M; Berger M; Vogel W; Judmaier G; Gastl G; Mull B; Flener R; Wiegele J
J Interferon Res; 1988 Oct; 8(5):655-64. PubMed ID: 3148671
[TBL] [Abstract][Full Text] [Related]
6. Biological and clinical effects of the combination of beta- and gamma-interferons administered as a 5-day continuous infusion.
Schiller JH; Storer B; Witt PL; Nelson B; Brown RR; Horisberger M; Grossberg S; Borden EC
Cancer Res; 1990 Aug; 50(15):4588-94. PubMed ID: 2114942
[TBL] [Abstract][Full Text] [Related]
7. Different lymphoid cell populations produce varied levels of neopterin, beta 2-microglobulin and soluble IL-2 receptor when stimulated with IL-2, interferon-gamma or tumour necrosis factor-alpha.
Hofmann B; Bass H; Nishanian P; Faisal M; Figlin RA; Sarna GP; Fahey JL
Clin Exp Immunol; 1992 Jun; 88(3):548-54. PubMed ID: 1606739
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of metastatic renal cell carcinoma with a biologically active dose of recombinant interferon-gamma.
Aulitzky W; Gastl G; Aulitzky WE; Herold M; Kemmler J; Mull B; Frick J; Huber C
J Clin Oncol; 1989 Dec; 7(12):1875-84. PubMed ID: 2511277
[TBL] [Abstract][Full Text] [Related]
9. Association between biosynthesis of nitric oxide and changes in immunological and vascular parameters in patients treated with interleukin-2.
Miles D; Thomsen L; Balkwill F; Thavasu P; Moncada S
Eur J Clin Invest; 1994 Apr; 24(4):287-90. PubMed ID: 8050458
[TBL] [Abstract][Full Text] [Related]
10. Interferon-gamma for the treatment of metastatic renal cancer: dose-dependent stimulation and downregulation of beta-2 microglobulin and neopterin responses.
Aulitzky W; Gastl G; Aulitzky WE; Nachbaur K; Lanske B; Kemmler G; Flener R; Frick J; Huber C
Immunobiology; 1987 Dec; 176(1-2):85-95. PubMed ID: 3129362
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of cytokines and cytokine-induced secondary messages in sera of patients after liver transplantation.
Tilg H; Vogel W; Aulitzky WE; Herold M; Königsrainer A; Margreiter R; Huber C
Transplantation; 1990 Jun; 49(6):1074-80. PubMed ID: 2163132
[TBL] [Abstract][Full Text] [Related]
12. Influence of immunotherapy (IL2 + LAK + inhibition of prostaglandin synthesis) on peripheral blood immune parameters and in vitro cytokine production in metastatic renal cell carcinoma.
Kleinknecht S; Bichler KH; Strohmaier WL
Urol Int; 1993; 50(3):121-8. PubMed ID: 8465478
[TBL] [Abstract][Full Text] [Related]
13. In vitro TNF-alpha, IL-2 and IFN-gamma production as markers of relapses in multiple sclerosis.
Philippé J; Debruyne J; Leroux-Roels G; Willems A; Dereuck J
Clin Neurol Neurosurg; 1996 Nov; 98(4):286-90. PubMed ID: 8930418
[TBL] [Abstract][Full Text] [Related]
14. Cytokine levels in acute alcoholic hepatitis: a sequential study.
Rodríguez-Rodríguez E; González-Reimers E; Santolaria-Fernández F; Milena-Abril A; Rodríguez-Moreno F; Oramas-Rodríguez J; Martínez-Riera A
Drug Alcohol Depend; 1995 Jul; 39(1):23-7. PubMed ID: 7587970
[TBL] [Abstract][Full Text] [Related]
15. [Interferon (IFN) therapy (recombinant IFN-alpha-2C or recombinant IFN-gamma) in metastasized hypernephroma].
Kuzmits R; Scheithauer W; Ludwig H; Flener R
Acta Med Austriaca; 1985; 12(5):129-34. PubMed ID: 3938590
[TBL] [Abstract][Full Text] [Related]
16. Changes of serum neopterin, beta 2-microglobulin and interferon-gamma in patients with chronic hepatitis C treated with interferon-alpha 2b.
Fuchs D; Norkrans G; Wejstal R; Reibnegger G; Weiss G; Weiland O; Schvarcz R; Fryden A; Wachter H
Eur J Med; 1992; 1(4):196-200. PubMed ID: 1341444
[TBL] [Abstract][Full Text] [Related]
17. Acute effects of single doses of recombinant interferon-gamma on blood cell counts and lymphocyte subsets in patients with advanced renal cell cancer.
Aulitzky WE; Aulitzky W; Gastl G; Lanske B; Reitter J; Frick J; Tilg H; Berger M; Herold M; Huber C
J Interferon Res; 1989 Aug; 9(4):425-33. PubMed ID: 2502583
[TBL] [Abstract][Full Text] [Related]
18. Clinical and biologic effects of combination therapy with gamma-interferon and tumor necrosis factor.
Schiller JH; Witt PL; Storer B; Alberti D; Tombes MB; Arzoomanian R; Brown RR; Proctor RA; Voss SD; Spriggs DR
Cancer; 1992 Jan; 69(2):562-71. PubMed ID: 1728387
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary sarcoidosis: patterns of cytokine release in vitro.
Prior C; Knight RA; Herold M; Ott G; Spiteri MA
Eur Respir J; 1996 Jan; 9(1):47-53. PubMed ID: 8834333
[TBL] [Abstract][Full Text] [Related]
20. Further evidence for lymphokine overproduction in severe aplastic anemia.
Hinterberger W; Adolf G; Aichinger G; Dudczak R; Geissler K; Höcker P; Huber C; Kalhs P; Knapp W; Köller U
Blood; 1988 Jul; 72(1):266-72. PubMed ID: 3134066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
